news
Merck to acquire Afferent Pharmaceuticals
10 June 2016 | By Victoria White, Digital Content Producer
Merck, known as MSD outside the US and Canada, has announced that it is is to acquire Afferent Pharmaceuticals...
List view / Grid view
Mergers & Acquisitions
news
Shire and Baxalta combine to create a global leader in rare diseases
3 June 2016 | By Victoria White, Digital Content Producer
Shire and Baxalta have combined businesses, creating a leading global company focused on rare diseases and other highly specialised conditions...
news
Jazz Pharmaceuticals to acquire Celator for $1.5 billion
31 May 2016 | By Victoria White, Digital Content Producer
The transaction advances Jazz Pharmaceuticals' growth strategy and adds Celator's investigational therapy Vyxeous to the company’s portfolio...
news
Sanofi files consent solicitation to replace Medivation’s Board
25 May 2016 | By Victoria White, Digital Content Producer
Sanofi says it had 'no choice' but to commence a process to elect eight independent directors who are more open to evaluating Sanofi's takeover proposal...
news
Jazz Pharmaceuticals acquires 100% of the shares of Alizé Pharma II
11 May 2016 | By Victoria White, Digital Content Producer
A subsidiary of Jazz Pharmaceuticals has acquired 100% of the shares of Alizé Pharma II in a deal valued at up to €18 million...
news
Incyte to acquire ARIAD’s European operations for $140m
9 May 2016 | By Victoria White, Digital Content Producer
The companies will also enter into a license agreement whereby Incyte will obtain an exclusive license to develop and commercialise Iclusig...
news
Ergomed proposes acquisition of Haemostatix
5 May 2016 | By Victoria White, Digital Content Producer
Ergomed is acquiring 100% of the issued share capital of Haemostatix for an initial consideration of £8.0 million...
news
Medivation’s Board rejects Sanofi’s unsolicited proposal
3 May 2016 | By Victoria White, Digital Content Producer
Medivation’s Board has determined that the proposal from Sanofi to acquire Medivation for $52.50 per share substantially undervalues the company...
news
Sanofi makes $9.3b offer to acquire Medivation
28 April 2016 | By Victoria White, Digital Content Producer
Sanofi has made an unsolicited $9.3 billion offer to acquire Medivation, the maker of prostate cancer drug Xtandi...
news
Allergan acquires topical dermatology company Topokine Therapeutics
22 April 2016 | By Victoria White, Digital Content Producer
Allergan has acquired Topokine Therapeutics for an upfront payment of $85 million and success-based development and sales milestones for XAF5...
news
ProStrakan rebrands as Kyowa Kirin International PLC
Kyowa Hakko Kirin (KHK), the company that acquired ProStraken in 2011, has decided that its western pharmaceutical subsidiaries are to adopt the Kyowa Kirin name...
news
Allergan and Pfizer terminate merger agreement
6 April 2016 | By Victoria White
The decision was driven by the actions announced by the US Department of Treasury, which the companies concluded qualified as an “Adverse Tax Law Change”...
article
Trends to transform healthcare in 2016
10 March 2016 | By Victoria White, European Pharmaceutical Review
In the latest issue of European Pharmaceutical Review, the Kaiser Associates European Healthcare team predict four trends to transform healthcare in 2016. We've created an infographic highlighting their key predictions...
news
Abbott to acquire diagnostics company Alere
1 February 2016 | By Victoria White
Abbott has announced that it is to acquire Alere, significantly advancing Abbott's global diagnostics presence and leadership.
news
Shire to acquire Baxalta in $32 billion deal
11 January 2016 | By Victoria White
The combination of Shire and Baxalta will create the number one rare diseases platform in revenue and pipeline depth...
